Home  »  Industry   »  Mirati Therapeutics Inc.: Analyzing MRTX Stock Tre...

Mirati Therapeutics Inc.: Analyzing MRTX Stock Trends

Mirati Therapeutics Inc. (MRTX) current stock price is $37.96. During the last trading session, the stock soared, reaching $45.52 after opening at $45.29. The stock’s lowest point was $43.65 before it closed at $43.84.

Mirati Therapeutics Inc.’s stock has had a tumultuous market performance. The 1-year high for the company’s stock was $101.30 on 11/28/22, and the lowest price during the same period was recorded at $32.96 on 05/27/22.

Unlock the Hottest Top 10 Penny Stocks Today! Discover Now

Dive into the world of lucrative penny stocks with MarketClub's groundbreaking "Smart Scan" technology! Get an instant snapshot of the top 50 high volume stocks with a clear direction and outstanding liquidity - in other words, the strongest trending. To unlock this exclusive list, simply provide your first name, last name, and email for instant access.

Gain Access to Top 10 Penny Stocks Now!.


52-week price history of MRTX Stock

Analyzing the 52-week price history of a stock, including its high and low prices, can provide valuable insight into its current status and potential future performance. Mirati Therapeutics Inc.’s current trading price is -62.53% away from its 52-week high, while its distance from the 52-week low is 15.17%. The stock’s price range for this period has remained between $32.96 and $101.30. The Healthcare sector company’s shares managed to surpass a trading volume of around 1.8 million for the day, which was noticeably higher compared to the shares’ average daily volume of 1.0 million over the last three months.

Financial Performance and Market Capitalization

Mirati Therapeutics Inc. (MRTX) has experienced a quarterly decline of -15.81% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 2.53B and boasts a workforce of 587 employees.

Analysts’ Ratings For Mirati Therapeutics Inc.

As of right now, 12 analysts are rating Mirati Therapeutics Inc. as a BUY, 1 of the polled analysts branded the stock as an OVERWEIGHT, 4 analysts are recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 analyst is rating the stock as SELL.

Moving average and trading volume data

Based on Barchart.com data, the company’s moving average over the 100-day period was 44.35, with a change in price of -7.27. Similarly, Mirati Therapeutics Inc. recorded 1,082,892 in trading volume during the last 100 days, posting a change of -16.05%.

MRTX Debt-to-equity ratio analysis

The debt-to-equity (D/E) ratio is a valuable metric that offers insight into a company’s financial health and standing in the market. This ratio is calculated by dividing a company’s current total liabilities by its shareholders’ equity. The D/E ratio illustrates the extent of debt a company is utilizing to support its assets in relation to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for MRTX stands at 0.00. Similarly, the long-term debt-to-equity ratio is also 0.00.

MRTX Stock Stochastic Average

As of today, the raw stochastic average of Mirati Therapeutics Inc. over the past 50 days is 14.36%. This is a increase compared to the raw stochastic average of the last 20 days, which was recorded at 3.82%. Additionally, the Stochastic %K and %D values for the company were 18.79% and 29.07%, respectively, over the past 20 days.

MRTX Stock Price Performance Analysis

Investors have been left with mixed emotions regarding the stock price performance over the year, as it’s been a mixed bag. Until today this year the stock’s price performance recorded a decrease of -16.22%. However, over the last six months, the performance has been stronger by -55.92%. The price of MRTX decreased -11.91% over the last 30 days. And in the last five days, it has fallen by -15.25%.

Leave a Comment

Your email address will not be published. Required fields are marked *

On Key

Related Posts